Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00923468 · ClinicalTrials.gov registry record
Pharmacokinetic Studies Participation Survey
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 25
- Enrollment target
NCT00923468: Completed study, sponsored by National Cancer Institute (NCI).
NCT00923468 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00923468 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
Background: * A pharmacokinetic (PK) study of a new drug involves taking several blood samples over a period of time from study participants to determine how the body handles the substance. These studies provide critical information about new drugs. * Often, patients or parents of children in drug studies choose not to participate in optional PK studies that are part of the study protocol. * A better understanding of why patients or families do or do not agree to participate in PK studies may help researchers make it easier for people to participate in them. Objectives: * To learn why some people do or do not agree to participate in PK blood sampling studies. Eligibility: * Patients 18 years of age and older and parents or guardians of children who are participating in a study of a drug that includes the option of participating in PK sampling. Design: * Participants fill out a 2-page survey asking about why they did or did not participate in the study's PK sampling.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2008-09-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00923468
The ClinicalTrials.gov registry entry for NCT00923468 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00923468 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00923468 about?
NCT00923468 is a clinical study titled "Pharmacokinetic Studies Participation Survey". Background: * A pharmacokinetic (PK) study of a new drug involves taking several blood samples over a period of time from study participants to determine how the body handles the substance. These studies provide critical information about new drugs. * Often, patients or parents of children in drug ...
What is the current status of trial NCT00923468?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2008-09-23.
Who is sponsoring clinical trial NCT00923468?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.